Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 15,056 shares at $2.15 ($33K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Open-market sale of $33k AKBA by SVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 7,400 | $16K | 48.9% |
| 2 | $2.17 | 1,100 | $2K | 7.3% |
| 3 | $2.17 | 6,556 | $14K | 43.7% |
| Total | $2.16 avg | 15,056 | $33K | 100% |
| Filing → |
| AKBA | SELL | 2025-02-04 | $163K | — | Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |